Calverley P - Search Results

1

Susceptibility to exacerbation in chronic obstructive pulmonary disease.

Hurst JR, Vestbo J, Anzueto A, Locantore N, Müllerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, Calverley P, Rennard S, Wouters EF, Wedzicha JA; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Hurst JR, et al. Among authors: calverley p. N Engl J Med. 2010 Sep 16;363(12):1128-38. doi: 10.1056/NEJMoa0909883. N Engl J Med. 2010. PMID: 20843247 Free article.

2

An observational study of inhaled corticosteroid withdrawal in stable chronic obstructive pulmonary disease. ISOLDE Study Group.

Jarad NA, Wedzicha JA, Burge PS, Calverley PM. Jarad NA, et al. Among authors: calverley pm. Respir Med. 1999 Mar;93(3):161-6. doi: 10.1016/s0954-6111(99)90001-x. Respir Med. 1999. PMID: 10464871 Free article. Clinical Trial.

3

Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey.

Rennard S, Decramer M, Calverley PM, Pride NB, Soriano JB, Vermeire PA, Vestbo J. Rennard S, et al. Among authors: calverley pm. Eur Respir J. 2002 Oct;20(4):799-805. doi: 10.1183/09031936.02.03242002. Eur Respir J. 2002. PMID: 12412667 Free article.

4

Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations.

Jones PW, Willits LR, Burge PS, Calverley PM; Inhaled Steroids in Obstructive Lung Disease in Europe study investigators. Jones PW, et al. Among authors: calverley pm. Eur Respir J. 2003 Jan;21(1):68-73. doi: 10.1183/09031936.03.00013303. Eur Respir J. 2003. PMID: 12570111 Free article. Clinical Trial.

5

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial.

Calverley P, Pauwels R, Vestbo J, Jones P, Pride N, Gulsvik A, Anderson J, Maden C; TRial of Inhaled STeroids ANd long-acting beta2 agonists study group. Calverley P, et al. Lancet. 2003 Feb 8;361(9356):449-56. doi: 10.1016/S0140-6736(03)12459-2. Lancet. 2003. PMID: 12583942 Clinical Trial.

6

Chronic obstructive pulmonary disease . 7: Management of COPD.

MacNee W, Calverley PM. MacNee W, et al. Among authors: calverley pm. Thorax. 2003 Mar;58(3):261-5. doi: 10.1136/thorax.58.3.261. Thorax. 2003. PMID: 12612309 Free PMC article. Review.

7

Rescue! Therapy and the paradox of the Barcalounger.

Rennard SI, Calverley P. Rennard SI, et al. Among authors: calverley p. Eur Respir J. 2003 Jun;21(6):916-7. doi: 10.1183/09031936.03.00111602. Eur Respir J. 2003. PMID: 12797481 Free article. No abstract available.

8

Chronic obstructive pulmonary disease.

Calverley PM, Walker P. Calverley PM, et al. Lancet. 2003 Sep 27;362(9389):1053-61. doi: 10.1016/s0140-6736(03)14416-9. Lancet. 2003. PMID: 14522537 Review.

9

COPD exacerbations: the importance of a standard definition.

Pauwels R, Calverley P, Buist AS, Rennard S, Fukuchi Y, Stahl E, Löfdahl CG. Pauwels R, et al. Among authors: calverley p. Respir Med. 2004 Feb;98(2):99-107. doi: 10.1016/j.rmed.2003.09.001. Respir Med. 2004. PMID: 14971871 Free article. Review.

10

Application of management guidelines to the assessment of new medicines: driving us forward or holding us back?

Calverley PM, Rennard SI. Calverley PM, et al. Eur Respir J. 2004 Jun;23(6):793-4. doi: 10.1183/09031936.04.00015904. Eur Respir J. 2004. PMID: 15218985 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

499 results

Search Page